HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quality of life in men treated with carbon ion therapy for prostate cancer.

AbstractPURPOSE:
To prospectively assess patient quality of life (QOL) after carbon ion radiotherapy (C-ion RT) for prostate cancer, using established questionnaires.
METHODS AND MATERIAL:
The subjects were 150 patients who underwent C-ion RT. Of these, 25 patients with low-risk prostate cancer received C-ion RT alone, whereas the remaining 125 patients with a high-risk tumor also received androgen deprivation therapy. Quality of life was assessed using the self-administered Functional Assessment of Cancer Therapy-Prostate (FACT-P) questionnaire in all patients three times. In addition, the University of California-Los Angeles Prostate Cancer Index (UCLA-PCI) was conducted in the low-risk patients.
RESULTS:
The FACT-General (FACT-G) and FACT-P scores at 12 months after treatment averaged over all 150 patients showed no significant change compared with those before C-ion RT. In FACT-P subscales, emotional well-being increased significantly just after and 12 months after treatment. In contrast, physical well-being (PWB) and social/family well-being (S/FWB) decreased significantly at 12 months, whereas the prostate cancer subscale (PCS) decreased significantly just after treatment. Average scores for FACT-G, FACT-P, PWB, S/FWB, and PCS for the 125 patients receiving hormone therapy showed substantial detrimental changes at 12 months. In contrast, those of the 25 low-risk patients who had no hormone therapy showed no significant change. Similarly no significant change in the average of the UCLA-PCI scores in the low-risk patients was seen at 12 months.
CONCLUSIONS:
Average QOL parameters reported by patients with localized prostate cancer treated with C-ion RT, in the absence of hormone therapy, showed no significant decrease 12 months after C-ion RT.
AuthorsMasaru Wakatsuki, Hiroshi Tsuji, Hitoshi Ishikawa, Takeshi Yanagi, Tadashi Kamada, Takashi Nakano, Hiroyoshi Suzuki, Koichiro Akakura, Jun Shimazaki, Hirohiko Tsujii
JournalInternational journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys) Vol. 72 Issue 4 Pg. 1010-5 (Nov 15 2008) ISSN: 1879-355X [Electronic] United States
PMID18495370 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Carbon Isotopes
Topics
  • Carbon Isotopes (therapeutic use)
  • Heavy Ion Radiotherapy
  • Humans
  • Japan (epidemiology)
  • Male
  • Prostatic Neoplasms (epidemiology, radiotherapy)
  • Quality of Life
  • Recovery of Function
  • Surveys and Questionnaires
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: